ProBiora Health acquires Oragenics’ consumer probiotic business

- Last updated on GMT

Image: © iStockPhoto / Kritchanut
Image: © iStockPhoto / Kritchanut

Related tags: Corporation

ProBiora Health, LLC, an entity owned by Ms. Christine L. Koski, has agreed to buy the consumer probiotic business of Oragenics, Inc. for $1.7 million in cash.

ProBiora Health will pay $1,250,000 at closing and $450,000 on or before July 31, 2016.

Dr Frederick Telling, Chairman of Oragenics, a developer of novel antibiotics against infectious disease and developing effective treatments for oral mucositis, said: “In December 2014 we announced that we were seeking strategic alternatives with respect to our Consumer Probiotics Business and, as a result of this process, we believe that this transaction is in the best interest of the Company and our shareholders as it will allow us to focus our efforts and resources on developing our novel antibiotics against infectious disease and on developing effective treatments for oral mucositis through our exclusive worldwide channel collaborations with Intrexon Corporation.”

Ms. Koski is a director as well as a significant shareholder of the Company through the Koski Family Limited Partnership. The sale is expected to close on or about June 24, subject to customary closing conditions.

Additional information is available in the company's Form 8-K​.

Related topics: Manufacturers, M&A, Probiotics & prebiotics

Related products

show more

Probiotics for Sports Nutrition

Probiotics for Sports Nutrition

Deerland Probiotics & Enzymes | 21-Jun-2019 | Application Note

A healthy gut and improved immune system are key factors to help overtake the competition. For athletes and fitness enthusiasts, optimizing digestion and...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars